Status:
UNKNOWN
Injectable Platelet Rich Fibrin With Collagen Matrix in Treatment of Multiple Gingival Recession.
Lead Sponsor:
University of Baghdad
Conditions:
Gingival Diseases
Traumatic Injury
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
This study is proposing the use of i-PRF clot as a scaffold for the XCM in order to obtain a novel biomaterial, incorporating active growth factors and collagen matrix in a single framework, based on ...
Eligibility Criteria
Inclusion
- Presence of at least two localized gingival recessions on either sides of the maxilla and/or mandible excluding molar region.
- The cemento-enamel junction (CEJ) is visible in the teeth for root coverage procedures.
- All recessions are type 1recession RT1 (cairo et al,2011) which correspond to Miller I\&II gingival recession
- All patients must demonstrate adequate plaque control with a fullmouth plaque score less than 20% and with .
- All patients at least 18 years of age and of both genders.
Exclusion
- Smoker Patients .
- Patients with diabetes.
- Patients with a history of malignancy, radiotherapy, or chemotherapy for malignancy.
- pregnant or nursing women.
- Patients taking medications or having treatments with an effect on mucosal healing in general (e.g. steroids, large doses of antiinflammatory drugs).
- Patients with a disease affecting connective tissue metabolism.
- Patients allergic to collagen.
Key Trial Info
Start Date :
April 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05389059
Start Date
April 25 2022
End Date
September 1 2023
Last Update
May 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Baghdad / College of Dentistry
Baghdad, Iraq, 10047